Tay Hwee Ling, Accounting & Reporting Assurance Leader, Deloitte Southeast Asia discusses why Southeast Asia saw a 9-year low for listings in 2024. She examines whether Singapore can rebound after being one of the worst performing in terms of IPO launches this year.

Produced/Presented: Ryan Huang

Tay Hwee Ling, Accounting &amp; Reporting Assurance Leader, Deloitte Southeast Asia discusses why Southeast Asia saw a 9-year low for listings in 2024. She examines whether Singapore can rebound after being one of the worst performing in terms of IPO launches this year.
Produced/Presented: Ryan Huang

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek (6am-9am)

Bigger Pic: How much will Singapore's IPO scene rebound in 2025?

As we say goodbye to 2024, it's time to test you on this year’s top stories! From turbulence and tech glitches, we’ve covered the highs, lows, and unexpected twists of 2024 on the Breakfast show.

How well did you do?

Presented by Audrey Siek, Emaad Akhtar & Ryan Huang 

Produced and Edited by Audrey Siek

Photo and music credits: Pixabay & its talented community of contributors

As we say goodbye to 2024, it's time to test you on this year&rsquo;s top stories!&nbsp;From turbulence and tech glitches, we&rsquo;ve covered the highs, lows, and unexpected twists of 2024 on the Breakfast show.
How well did you do?
Presented by Audrey Siek, Emaad Akhtar &amp; Ryan Huang&nbsp;
Produced and Edited by Audrey Siek
Photo and music credits: Pixabay &amp; its talented community of contributors

Breakfast Quiz: 2024 was a wild ride! How well do you know what happened?

Marcus Chu, CEO of ERA Singapore, ERA Asia Pacific and APAC Realty, shares what were the bright spots in the property market in 2024, and where prices are heading to next year. He also discusses the risk of further cooling measures if the market continues to heat up.

Produced/Presented: Ryan Huang

Marcus Chu, CEO of ERA Singapore, ERA Asia Pacific and APAC Realty, shares what were the bright spots in the property market in 2024, and where prices are heading to next year. He also discusses the risk of further cooling measures if the market continues to heat up.
Produced/Presented: Ryan Huang

Bigger Pic: Risk of further property cooling measures as market closes 2024 on a high?

The pharmaceutical industry is on the cusp of a transformation, driven by cutting-edge technologies like 3D printing. GMP, a leading UK-based contract manufacturer specializing in pharmaceuticals, cosmetics, and healthcare products, is pioneering this shift.

With a platform that combines hardware, software, and formulation solutions, GMP enables customizable, small-batch medicines tailored to individual needs. 

What does this mean for the future of personalized medicine? 

Here’s our conversation with Giby George, Group CEO, GMP

The pharmaceutical industry is on the cusp of a transformation, driven by cutting-edge technologies like 3D printing. GMP, a leading UK-based contract manufacturer specializing in pharmaceuticals, cosmetics, and healthcare products, is pioneering this shift.
With a platform that combines hardware, software, and formulation solutions, GMP enables customizable, small-batch medicines tailored to individual needs.&nbsp;
What does this mean for the future of personalized medicine? 
Here&rsquo;s our conversation with&nbsp;Giby George, Group CEO, GMP

Bigger Pic: How much will Singapore's IPO scene rebound in 2025?

In 1 playlist(s)

Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek (6am-9am)

Social links

Follow podcast

Recent clips